GSTM1 and chronic kidney disease: As indicated in the literature (Doshi et al., 2013), CKD patients on dialysis with a baseline Hb of 8 g/dL may need 10–15 weeks of treatment, while those with a baseline Hb near 10 g/dL may need only 6–8 weeks.